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17-Estradiol  and  testosterone  signiﬁcantly  increased  the neural  cell  proliferation.
Estradiol  and  testosterone  increased  mature  BDNF  level  and  its mRNA  expression  in neural  cell.
Effect  of testosterone  on  cell  proliferation  required  neurotrophin  receptor  activation.
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To  determine  the  effects  of  gonadal  hormones  on proliferation  of the  hippocampal  neural  cells,  which  are
of  importance  in learning  and  memory  function.  17-Estradiol  or testosterone  was  added  to  the  culture
at  various  concentrations.  Their  proliferation  and  protective  effects  on the  neural  cell were  determined
with  BrdU,  ﬂow  cytometry  and  MTT  assay.  Effects  of  the  gonadal  hormones  on  brain-derived  neu-
rotrophic  factor  (BDNF)  expression  were  determined  using  ELISA  and  RT-PCR  respectively.  17-Estradiol
and  testosterone  at 20 nM  or  higher  concentrations  signiﬁcantly  increased  the neural  cell  proliferationrain-derived neurotrophic factor (BDNF)
roliferation
ippocampal neural cell
and  viability,  and  induced  increasing  in  the S phase  arrest  which  is  essential  for cell  proliferation.  Both
estradiol  and  testosterone  signiﬁcantly  increased  the neural  cell  expression  of  cellular  mature  BDNF
and  BDNF  mRNA.  Effect  of  testosterone  on hippocampal  neural  proliferation  was  blocked  by Trk  neu-
rotrophin  receptor  inhibitor.  17-Estradiol  and  testosterone  promoted  hippocampal  neural  proliferation
and  improved  cell  viability  in  vitro. The  effect  of  testosterone  on  hippocampal  neural  cell  proliferation
required  neurotrophin  receptor  activation.
he A© 2013 T
. IntroductionIt has been reported that verbal memory declines with the loss
f estrogen production in elderly women and the memory loss can
e prevented by estrogen replacement therapy (ERT) at the early
Abbreviations: BDNF, brain-derived neurotrophic factor; p75NTR, p75 neu-
otrophin receptor; TrkB, tyrosine kinase receptors B; LTP, long-term potentiation;
GF,  neurotrophic growth factor; DMEM,  Dulbecco’s modiﬁed Eagle’s medium;
MSO, dimethyl sulfoxide; RT-PCR, reverse transcription polymerase chain reaction.
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state of menopause [7]. It has also been reported that early ERT in
post-menopause women may  reduce the risk of Alzheimer’s dis-
ease [27]. In both elderly men  and women  the risk of Alzheimer’s
disease increases with age [11], and the decline in androgen levels
and subsequently diminishing of estrogen in elderly men  has been
suggested to contribute to the age-associated memory loss [3].
It  has been proposed that estrogen may  act on central neurons
via a direct genomic pathway [24] or indirectly through mitogen-
activated protein kinases [20], cAMP-responsive element binding
protein [29] or neurotrophic factors [3]. It was  reported that estro-
gen deprivation in rats reduced brain-derived neurotrophic factor
(BDNF) expression, while ERT restored the BDNF level in the brain
tissue [3]. BDNF is known to play important role in neuronal growth,
survival and plasticity formation [1]. The BDNF/tyrosine kinase
receptors B (TrkB) system expresses in the hippocampus region and
Open access under CC BY-NC-ND license.plays a crucial role in memory acquisition and retention [16]. On
the other hand, current studies presumed that testosterone may  act
through androgen (directly or conversion to dihydrotestosteraone),
estrogen (via aromatase conversion) [17] pathways, androgen
-NC-ND license.
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eceptor activation [4], and increasing neurotrophic growth fac-
or (NGF) levels and induced up-regulation of p75-NGFr in brain
n adult male rats [23]. Therefore, testosterone level may  account
or male’s susceptibility to Alzheimer’s disease as well as estrogen
or female, and the effects of testosterone on hippocampus may
e mediated by BDNF expression. In present study, we examined
he effects of gonadal hormones on fetal rat hippocampal neural
ells proliferation and survival in vitro, BDNF expression, and the
ubsequent role of BDNF on the neural proliferation.
. Materials and methods
.1.  Cell culture
Fetal  rat hippocumpal neural cells (H19-7/IGF-IR) were pur-
hased from ATCC (No.CRL-2526, USA). The cells were maintained
t 34 ◦C in a humidiﬁed atmosphere at 5%CO2 in phenol-red free
ulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with
0% fetal bovine serum, 200 g/ml geneticin (Sigma), 0.001 mg/ml
uromycin (Sigma) and 2 mM l-glutamine (Sigma). For experi-
ents, neural cells were trypsinized with 0.25% trypsin-EDTA,
hen suspended in complete DMEM and seeded at a density of
.0 × 105 cells/ml in 96-well plate. The cells were cultured to
pproximately 80% conﬂuence, then the complete DMEM was
eplaced with FBS-free medium with different concentrations of
7-estradiol (E, Sigma) and testosterone (T, Fluca) respectively.
17-Estradiol or testosterone was dissolved in pure ethanol
ith 0.001% ethanol as the ﬁnal concentration of vehicle in the
edium, a concentration without cytoxicity in previous experi-
ents. The cells received treatment of 0.001% ethanol at the ﬁnal
oncentration of vehicle in the medium as control group. K252a
Sigma), a selective inhibitor of the tyrosine kinase Trk family of
eurotrophin receptors [8], was dissolved in dimethyl sulfoxide
DMSO, Sigma). 200 nM K252a in DMEM containing 0.01%DMSO
as added 2 h prior to the addition of gonadal hormones.
.2.  Assessment of cell viability and proliferation
Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-
l)-2,5-diphenyl tetrazolium bromide (MTT, Sigma) colorimetric
ssay [15]. Brieﬂy, MTT  was added to the culture at a ﬁnal concen-
ration of 0.5 mg/ml  and incubated for 4 h. The intracellular purple
ormazans in living cells were dissolved in lyses buffer (10%SDS,
.01 M HCl) overnight. The optical density was measured at 595 nm
n micro-plate reader (Bio-Rad).
The percentage of 5-bromo-2′-deoxyuridine (BrdU) incorpo-
ated cells were determined using BrdU labeling ELISA kit (Roche,
SA). BrdU labeling was determined by immunoassay following the
anufacturer’s instructions. The reaction product was quantiﬁed
y the measurement of absorbance at 450 nm/655 nm.
.3. Cell cycle analysis by ﬂow cytometry
The cell cycle phase distribution was assessed using ﬂow cytom-
try. Brieﬂy, the cells were harvested with PBS and re-suspended
n chilly 75% ethanol at 4 ◦C overnight, then incubated in 0.5 ml
f staining solution containing 50 g/ml propidium iodide and
0 g/ml RNAase in PBS at 37 ◦C for 2 h. Approximately 10,000 cells
er sample were collected for analysis with EPICS-XL (Beckman).
he percentages of cells in each cell cycle phase were calculated
sing WinMDI v2.8 software. Each sample was tested three times..4.  Measurement of BDNF protein expression
Cells were harvested in 4 ◦C PBS and centrifuged for 5 min  at
800 rpm at 4 ◦C. Cell pellets were sonicated for 20 s at 3 W in Letters 546 (2013) 1– 5
50  l lysis buffer (0.1% (v/v) Triton X-100, 50 mM Tris–HCl (pH 7.0),
200 mM NaCl, 10 mM CaCl2, 0.5% NaN3, and 1% protease inhibitors
cocktail), then centrifuged at 15,000 × g for 30 min at 4 ◦C. The
resulting supernatants were used for measurements of cellular pro-
tein [5] and BDNF levels.
Mature  BDNF was measured using BDNF-Emax ImmunoAs-
say System (Promega) following manufacturer’s instructions. The
cellular concentrations of BDNF in the samples were calculated
from the rhBDNF standard curve by linear regression analysis, and
expressed as pg/mg protein.
2.5.  Semi quantiﬁcation of BDNF mRNA expression
Reverse transcription polymerase chain reaction (RT-PCR) was
used to evaluate the expression levels of BDNF mRNA and using
GAPDH mRNA as the internal control. Primers speciﬁc to BDNF
and GAPDH were designed from public sequences using Primer 3
software and the sequences of the PCR primers were as follows:
BDNF Sense: 5′ TGTGACAGTATTAGCGAGTGGGT 3′, anti-sense: 5′
CGATTGGGTAGTTCGGCATT 3′; GAPDH Sense: 5′ AAGTTCAACG-
GCACAGTCAAGG 3′, anti-sense 5′ GCACCAGTGGATGCAGGGAT 3′.
Total RNA was extracted using TRIzol reagent (Invitrogen), and
reverse transcription (RT) reactions were performed in duplicates
in SuperScript First-strand Synthesis System (Invitrogen) accord-
ing to the manufacture’s instructions respectively. Conditions of
PCR ampliﬁcation were as follows: BDNF, denaturation at 94 ◦C for
30 s, annealing at 50 ◦C for 30 s, extension at 68 ◦C for 15 s; GAPDH,
denaturation at 94 ◦C for 30 s, annealing at 57 ◦C for 30 s, extension
at 68 ◦C for 30 s. 5 l of PCR products was  resolved by 1% agarose
gel electrophoresis, stained with ethidium bromide and visualized
under UV light. The density of PCR products was  analyzed by Quan-
tity One software (Bio-Rad). Results are expressed as the ratios of
BDNF mRNA to GAPDH mRNA from the identical sample.
2.6.  Statistical analysis
All  data are presented as mean ± SEM of two  or more repeated
independent experiments, and 6–8 replicate per experiment. Sta-
tistically signiﬁcant differences were determined by Student’s
t-test for two-group comparisons, and by one-way ANOVA followed
by Student–Newman–Keuls post hoc analysis for multi-group com-
parisons. Statistical analyses were performed using SPSS v15.0
(SSPS Inc.). A P value of <0.05 was considered statistically signif-
icant.
3. Results
3.1. Gonadal hormones increased cell viability of H19-7/IGF-IR
cells
Compared to the control group, treatments with 20, 200 and
2000 nM of 17-estradiol for 72 h signiﬁcantly increased the cell
viability in H19-7/IGF-IR cells from 7% to 11% (P < 0.05, F = 8.824,
Fig. 1). The cell viability of cultures receiving 200 nM or 2000 nM
of testosterone was signiﬁcantly higher than that of control group
respectively (P < 0.05, F = 4.478), and the magnitude of the testos-
terone induced reduction of cell viability ranged from 6% to 8%.
3.2.  Gonadal hormones promoted H19-7/IGF-IR cells proliferation
To determine whether the increase of cell population is resulted
from cell proliferation, the percentage of BrdU incorporated cells in
cultures were determined after treatment of 20 nM and 200 nM of
17-estradiol and testosterone, respectively. We  found that 17-
estradiol signiﬁcantly promoted the cell proliferation by around
33% at 20 nM and 36% at 200 nM compared to the control culture
M. Pan, C. Zhang / Neuroscience Letters 546 (2013) 1– 5 3
Fig. 1. Cell viability of H19-7/IGF-IR cells determined by MTT assay. Compared to
the control cells (white), treatments with of 17-estradiol (white spotted) for 72 h
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Fig. 3. BDNF mRNA expressions in H19-7/IGF-IR cells. BDNF mRNA level in cells
with  17-estradiol treatment (band E, white spotted) for 48 h was  higher than the
control cells (band C, white) (P < 0.05). BDNF mRNA level in cells with testosteroneigniﬁcantly increased the cell viability from 7% to 11% (P < 0.05). The cell viability
f  cultures receiving testosterone (gray spotted) was signiﬁcantly higher than that
f control cells respectively (P < 0.05). *: vs control group, P < 0.05.
P < 0.05, F = 9.457 and F = 9.913, Fig. 2A). Testosterone signiﬁcantly
romoted cell proliferation by around 25% at 20 nM and 17% at
00 nM (P < 0.05), respectively. The effect of estradiol was  more
otent than that of testosterone at 200 nM (P < 0.05).
Cell cycle analyses showed that 17-estradiol and testosterone
licited an increase in the percentage of hippocampus neural cells
n S phase, an essential phase for cell proliferation, at 200 nM
ig. 2. H19-7/IGF-IR cells proliferation determined by BrdU assay and ﬂow cytom-
try. 17-Estradiol (white spotted) promoted the cell proliferation by around 33%
t 20 nM and 36% at 200 nM compared to the control cells (white) (P < 0.05), while
estosterone  (gray spotted) promoted cell proliferation by around 25% at 20 nM and
7% at 200 nM (P < 0.05, A), respectively. 17-Estradiol and testosterone elicited an
ncrease in the percentage of cells in S phase as compared to the control group
P  < 0.05, B). *: vs control group, P < 0.05.treatment  (band T, gray spotted) for 24 h or 48 h was higher than the control cells
respectively (P < 0.05). (A) and (B) PCR products with treatment for 24 h and 48 h;
(C) Histogram of BNDF mRNA expression. *: vs control group, P < 0.05.
[(17.73 ± 0.51)% and (18.92 ± 0.26)% respectively] as compared to
the control group [(14.21 ± 1.75)%] (P < 0.05, Fig. 2B).
3.3.  Gonadal hormones increased BDNF expression
Compared to the control group, BDNF mRNA level in H19-7/IGF-
IR cells signiﬁcantly increased with treatment of 17-estradiol for
48 h (P < 0.05, F = 5.425, Fig. 3), and testosterone for 24 h and 48 h
(P < 0.05, F = 7.539, Fig. 3), respectively. Compared to the control
group, 17-estradiol increased cellular BDNF level at 24 h after
treatment (P < 0.05, F = 4.327, Fig. 4A). While testosterone increased
cellular BDNF level at 24 h and 48 h after treatment (P < 0.05,
F = 5.301, Fig. 4A). No difference in cellular BDNF expression was
observed at 72 h after treatment for any groups. And no difference
in supernatant BDNF expression was  observed after treatment for
any groups (Fig. 4B).
3.4.  Effect of Trk receptors inhibitor on gonadal
hormones-induced H19-7/IGF-IR cells proliferation
Pre-treatment with K252a, a selective Trk receptors phosphory-
lation inhibitor, signiﬁcantly decreased cells proliferation (P < 0.05,
t = 3.389, Fig. 5), indicating that Trk pathway contributed to the reg-
ulation of cell proliferation in these cells. Pre-treatment with K252a
blocked the effect of testosterone on cells proliferation (P < 0.05,
F = 3.996, Fig. 5), suggesting the requirement of Trk receptors
activation in testosterone-mediated effects on neural cell prolif-
eration. Pre-treatment with K252a did not abolish the effect of
17-estradiol on cell proliferation.
4.  Discussion
The present study demonstrated that 17-estradiol and
testosterone promoted fetal hippocampal neural cell prolifera-
tion and viability. Testosterone and 17-estradiol increased the
cellular BDNF level and BDNF mRNA expression. Effect of testos-
terone on the cell proliferation was blocked selective inhibitor of
4 M.  Pan, C. Zhang / Neuroscience
Fig. 4. Mature BDNF level in H19-7/IGF-IR cells. Time course of cellular (A) and
supernatant  (B) BDNF level with 17-estradiol (10 nM)  and testosterone (20 nM)
treatment respectively. Compared to the control (white), 17-estradiol (white spot-
t
t
m
n
t
e
d
s
i
g
m
p
m
a
c
F
t
P
p
oed) increased cellular mature BDNF level at 24 h of treatment (P < 0.05), while
estosterone  (gray spotted) increased cellular BDNF level at 24 h and 48 h of treat-
ent (P < 0.05, A). *: vs control group, P < 0.05.
eurotrophin receptor (Trk), suggesting that the effects of
estosterone might require neurotrophin receptor activation.
Hippocampal neurogenesis has been reported to involve in the
ffects of antidepressants [21], performances on a hippocampal
ependent task and recovery from injury [25,26]. New neurons,
ince they are structurally plastic, are highly susceptible to changes
n the environment and different life experiments [12]. Newly
enerated cells in the adult mouse hippocampus have neuronal
orphology and can display passive membrane properties, action
otentials and functional synaptic inputs similar to those found in
ature dentate granule cells [26]. It was reported that testosterone
nalog alone increased the number of BrdU labeled neural stem
ell (NSC) in embryonic culture [6]. Ovarian steroids increase the
ig. 5. Effect of K252a on gonadal hormones-induced cell proliferation. Pre-
reatment  with K252a decreased H19-7/IGF-IR cells proliferation (*P < 0.05).
re-treatment  with K252a blocked the effect of testosterone (gray spotted) on cell
roliferation (P < 0.05) but did not abolish the effect of 17-estradiol (white spotted)
n  cell proliferation. *: vs control group, P < 0.05. Letters 546 (2013) 1– 5
proliferation of granule cell precursors in the dentate gyrus of the
adult animals [18,22]. It was found here that estrogen and testos-
terone exert effect on promoted proliferation in H19-7/IGF-IR cells
using BrdU assay. These results supported the epidemiological
studies demonstrated that women using hormone replacement
therapy performed signiﬁcantly better on a visual memory test in
a cross-sectional study [13]. In view of roles of hippocampal neu-
rogenesis, it would be important for the neural development and
survival in adults. Our ﬁndings raised the possibility that effects of
gonadal hormones on promoted proliferation and improved via-
bility could help prevention or improvement of neurodegenerative
disease.
Neurotrophins are key signaling molecules in the development
of the nervous system. They elicit diverse cellular responses such as
proliferation, differentiation, survival and apoptosis [10]. Initially
synthesized as precursors, neurotrophins are cleaved to produce
mature proteins, which promote neural survival and enhance
synaptic plasticity by activating Trk receptor tyrosine kinases [2]. It
was reported that endogenous produced neurotrophins (BDNF and
NT-3) and high-afﬁnity Trk-mediated signaling pathways mediated
cortical progenitors and microglial cells survival and neurogene-
sis [28]. Exogenous BDNF has effects on postsynaptic excitability
and Ca2+ signaling in the dentate granule cell, and the postsynaptic
BDNF-TrkB pathway is crucial for regulation of excitatory synap-
tic transmission and long-term potentiation (LTP) induction, which
is an important synaptic connection model of memory formation
[14].
Our data showed that BDNF expression displayed a time-
dependent increasing in control culture, while estradiol and
testosterone had more potent effect on promoting neural cells pro-
liferation compared with the controls. This result indicated that
BDNF played an important role in protection and/or reparation
on cell model of cytotoxicity and gonadal hormone may  have the
beneﬁcial effect through enhanced BDNF expression. Testosterone
increased BDNF expression [19] and promoted cell growth, dif-
ferentiation, morphology, survival in center neuronal system [9],
suggested that BDNF might media the effects of gonadal hormones
on neural cells proliferation. K252a signiﬁcantly slowed down the
neural cell proliferation in the present study, indicating that Trk
receptor also contributed to the hippocampal neural cell prolif-
eration. Additionally, K252a blocked the proliferation promoting
activity of testosterone, indicating that activation of Trk receptor
was required for testosterone to mediate its effect on hippocam-
pal neural cell proliferation. Therefore, testosterone might enhance
hippocampal neurogenesis via directly increased cell proliferation
through a neurotrophin receptor activation dependent mechanism.
While estradiol may  promote cell proliferation through BDNF stim-
ulation and other pathways at the same time.
Gonadal hormones replacement therapy has been proved to
be an effective for aging related diseases. Although some discrep-
ancy results have been reported, it is probably that the time point
of treatment is important to get a beneﬁcial effect. These results
showed an important new lead in the prevention and treatment
against neurodegenerative diseases with aging of neurodegenera-
tive diseases.
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